Generation Bio Co (GBIO) - חוב להון עצמי

The market trend for Generation Bio Co. (GBIO) shown on this price chart demonstrates a debt-to-equity ratio of 0.56. The business focuses on creating breakthrough non-viral genetic material delivery methods. Unique patents and strict FDA oversight ensure a high barrier to entry. Current R&D expenses are funded by existing cash reserves.

Steady demand for Generation Bio Co. (GBIO) biotechnological innovations insulates the business from macroeconomic shocks, creating a foundation for sustainable growth. Analyzing the company's financial leverage dynamics, an investor assesses the debt-to-equity ratio to determine the level of debt burden and the risk of losing control over assets to creditors.